- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07469020
CLE-PAD : Prevalentie van PAD bij Patiënten Met Chirurgische Lumbale Spinale Stenose (CLE-PAD)
CLE-PAD : Prevalentie van perifeer vaatlijden van de onderste ledematen bij patiënten met chirurgisch behandelde lumbale spinale stenose
The goal of this interventional study is to evaluate the rate of existing lower limb peripheral artery disease (PAD) in patients with surgically lumbar spinal stenosis (LSS). PAD and LSS can present similar symptoms and it can be difficult to diagnose PAD using conventional methods, depending on the location of the arterial disease. The main questions it aims to answer are :
- What's the prevalence of PAD in LSS patients?
- Which exam among routine tools is the most accurate to diagnose PAD in this population? Around their surgery for LSS (a few weeks before or after), participants will be included in a vascular medicine service. After checking of eligibility criteria, they will undergo a contrast-enhanced CT scan for the diagnosis of PAD and various routine diagnostic tests: Doppler ultrasound, treadmill tests, pressure index, pulse palpation.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Lumbar spinal stenosis (LSS) is a debilitating degenerative condition in older people associated with lower back pain, pain in the lower limbs and a reduced quality of life. LSS can be treated surgically, but the results are mixed: 35% of patients report low satisfaction one year after surgery. The symptoms of LSC in the lower limbs can mimic those associated with peripheral arterial disease (PAD). The prevalence of PAD in the LSC population varies between 4.1% and 67.8% depending on the diagnostic tests used and the populations studied. Thus, the precise analysis of the prevalence of PAD and the sensitivity and specificity of PAD diagnostic tests in this population remain to be determined. These analyses would help to optimise PAD diagnostic tools, while possibly providing an explanation for the post-operative persistence of functional discomfort in CLE patients. Furthermore, a better understanding of the vascular system in the CLE population offers hope for optimising patient care, both from a medical and a medico-economic point of view.
The experimental visit takes place as soon as possible after receipt of the biological assessment and within a maximum period of 3 months. During this visit, specific research examinations will be performed, including stress tests (stress TcPO2 according to the modified Strandness protocol and stress TcPO2 according to the Gardner-Skinner increasing load protocol), as well as an injected scan of the aorta of the lower limbs. The pseudonymised CT scan will be sent to the sponsor for blind review. A follow-up telephone call will be made between 7 and 10 days after the CT scan to detect the occurrence of any adverse events. The study will then be completed for the participant.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Marie-Laure Gervais
- Telefoonnummer: +33299284321
- E-mail: marie-laure.gervais@chu-rennes.fr
Studie Locaties
-
-
-
Lille, Frankrijk
- Nog niet aan het werven
- Groupement des Hôpitaux de l'Institut Catholique de Lille
-
Contact:
- Marjolaine Talbot
- Telefoonnummer: +33320225000
- E-mail: talbot.marjolaine@ghicl.net
-
Hoofdonderzoeker:
- Marjolaine Talbot
-
Paris, Frankrijk
- Werving
- Groupe hospitalier Paris Saint Joseph
-
Contact:
- Ewa Tuleja
- Telefoonnummer: +33144127137
- E-mail: etuleja@ghpsj.fr
-
Hoofdonderzoeker:
- Ewa Tuleja
-
Rennes, Frankrijk
- Werving
- CHU Rennes
-
Contact:
- Marie Charasson
- Telefoonnummer: +33299284321
- E-mail: marie.charasson@chu-rennes.fr
-
Hoofdonderzoeker:
- Marie Charasson
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Presenting with a lumbar spinal stenosis with surgical indication, either unoperated or operated on less than 3 months ago
- Affiliated with a social security scheme
- Having received oral and written information about the protocol and having signed a written consent form to participate in this research.
Exclusion Criteria:
-
emergency surgical care
-
Contraindication to contrast enhanced CT scan
- Stroke or myocardial infarction (MI) within the last 3 months
- Known severe or poorly tolerated arrhythmia
- Known severe or symptomatic left ventricular outflow obstruction
- Decompensated heart failure
- History within the last 3 months of venous thromboembolic disease, myopericarditis, endocarditis, aortic dissection or intracardiac thrombus
- Severe uncontrolled hypertension (BP > 200/110 mmHg)
- Inability to walk on the treadmill
- Major lower limb amputation
- Adult subject to legal protection
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Diagnostisch
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Deelnemers
|
contrast-enhanced CT scan |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Number of patients with PAD identified during the contrast enhanced CT scan
Tijdsspanne: 3 months
|
Number of patients with PAD identified during the contrast enhanced CT scan. PAD will be defined by the presence of at least one arterial stenosis ≥ 50% on the arterial axes located from the abdominal aorta to the origin of the tibiofibular arterial trunk, as determined by CT scan of the aorta and lower limbs in accordance with the recommendations. |
3 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Efficiency of diagnosis test "pulse"
Tijdsspanne: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "pulse" : the absence of distal pulses will be considered pathological |
3 months
|
|
Efficiency of diagnosis test "systolic pressure index"
Tijdsspanne: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "systolic pressure index" : A resting systolic pressure index ≤ 0.90 will be considered pathological in accordance with the recommendations. |
3 months
|
|
Efficiency of diagnosis test "toe systolic pressure index"
Tijdsspanne: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "toe systolic pressure index" : A resting toe systolic pressure index ≤ 0.70 will be considered pathological in accordance with the recommendations. |
3 months
|
|
Efficiency of diagnosis test "Aorto-iliac and lower limb Doppler ultrasound"
Tijdsspanne: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "Aorto-iliac and lower limb Doppler ultrasound " : velocimetric criteria for stenosis and Saint-Bonnet B and CD, E and 0 Doppler curves considered pathological (i.e. AOMI) in accordance with recommendations . |
3 months
|
|
Efficiency of diagnosis test "exercise oxymetry"
Tijdsspanne: 3 months
|
determination of the sensitivity and specificity, positive predictive value and negative predictive value of the diagnostic test "exercise oxymetry " : Delta from rest oxygen pressure (DROP) ≤ -15 mmHg will be considered pathological (i.e. AOMI) in accordance with the recommendations. . |
3 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie stoel: Marjolaine Talbot, Groupement des Hôpitaux de l'Institut Catholique de Lille
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 35R24_8825_04_CLE-PAD
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .